GSK‐3β is a key regulator of NF‐κB in pancreatic cancer cells, which controls the expressions of genes governing cell proliferation, apoptosis, inflammation, angiogenesis, infiltration, and drug resistance [30]. Here, NFKB1 is linked to pancreatic neoplasm.